Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. (OTCBB:WLSI) has announced they have started their second Beta Test in a Long Term Care Facility.

Wellstar has implemented its second TMI Imaging system; this system will help in not only diagnosing but predicting deep tissue injuries which then can develop into bed sores. By detecting early tissue damage, the success of avoiding bed sores is greatly increased. TMI views this as one of the last steps to be able to implement its system in the LTAC market. With more than 700 LTAC's across the United States, TMI anticipates in excess of revenues that could exceed more than 1 million dollars per month from this segment of the marketplace.

Long term acute care facilities or LTAC's, are facilities that generally house immobile patients and those patients are considered high-risk in developing a pressure ulcer. TMI plans to use its technology with the nurses on call to monitor and help diagnose any change in the patient's tissue around the specified areas.

The Beta Test is scheduled to run for 90 days. During this period, images will be captured of existing patients on a time schedule, as well as any new patient admitted to the facility will also be imaged. The data that will be compiled will be used to determine the type of specific care for the patient, as well as to demonstrate the practical use of the TMI System within the workplace.